<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mpath ids='MPATH_481'>Pre-neoplastic lesions</z:mpath> (ACF, <z:mpath ids='MPATH_557'>aberrant-crypt-foci</z:mpath>; Hp, hyperplastic/dysplastic <z:mpath ids='MPATH_491'>polyps</z:mpath>) are believed to be precursors of <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal-tumors</z:e> (Ad, <z:mpath ids='MPATH_270'>adenomas</z:mpath>; AdCA, <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>) </plain></SENT>
<SENT sid="1" pm="."><plain>ACF/Hp likely originate due to abnormal growth of colonic-crypts in response to aberrant queues in the microenvironment of colonic-crypts </plain></SENT>
<SENT sid="2" pm="."><plain>Thus identifying factors which regulate homeostatic vs aberrant proliferation/<z:mpath ids='MPATH_3'>apoptosis</z:mpath> of colonocytes, especially stem/progenitor cells, may lead to effective preventative/treatment strategies </plain></SENT>
<SENT sid="3" pm="."><plain>Based on this philosophy, role of growth-factors/<z:chebi fb="0" ids="25905">peptide-hormones</z:chebi>, potentially available in the circulation/microenvironment of colonic-crypts is being examined extensively </plain></SENT>
<SENT sid="4" pm="."><plain>Since the time gastrins were discovered as trophic (growth) factors for gastrointestinal-cells, the effect of gastrins on the growth of <z:mpath ids='MPATH_458'>normal</z:mpath>/<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells has been investigated, leading to many discoveries </plain></SENT>
<SENT sid="5" pm="."><plain>Seminal discoveries made in the area of gastrins and <z:hpo ids='HP_0003003'>colon-cancer</z:hpo>, as it relates to molecular pathways associated with formation of <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colonic tumors</z:e> will be reviewed, and possible impact on diagnostic/preventative/treatment strategies will be discussed </plain></SENT>
</text></document>